RE: Roots2 Aug 2017 09:00
Lush had turnover in the year ending Jun 16 of £394.9m, PBT £43.2m (10.9%), 820+ stores.
Innovaderma are expecting turnover in the year ending Jun 16 of £9m, PBT £1.3m (14.4%) excluding one-offs (moving production to UK).
Two different business models. Lush relies primarily on a bricks & mortar estate operating under their brand name and absorbing all associated costs. Innovaderma forgo that overhead burden by focusing on their DTC platform and supply to other retailers.
I'd expect Innovaderma's cost base to remain low and margins to improve, particularly with the move into the Hair Loss/PE markets (eg. 90% margin on £250 Prolong devices). NP%, ROCE etc should all be better.
Let's not forget also that we are tapping into several multi-billion £ markets. Bronzing, skin brightening and anti-ageing, skin care, cosmetics, hair loss, PE, etc. What's next?
If we take the bronzing market alone, our UK sales of ST are approximately £7m p.a. and growing rapidly. This is in a £60m market. The US market is closer to $1bn (13-15x the size). If we replicate the success across the pond, that could be £100m+ on the top line.
The skin brightening market is 23-25x the size of the bronzing market. Relative success could mean hundreds of millions. Starts adding up doesn't it? The company are demonstrating their ability to create speed and scale.
NYX cosmetics achieved sales of $93 million in 2013 and was acquired by L'Oreal for $500m. Stevie K could be the next star.